- Home
- CDXC vs ASPI Comparison
CDXC vs ASPI Comparison
Compare CDXC & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXC
- ASPI
- Stock Information
- Founded
- CDXC 1999
- ASPI 2021
- Country
- CDXC United States
- ASPI United States
- Employees
- CDXC N/A
- ASPI N/A
- Industry
- CDXC Medicinal Chemicals and Botanical Products
- ASPI Major Chemicals
- Sector
- CDXC Health Care
- ASPI Industrials
- Exchange
- CDXC Nasdaq
- ASPI Nasdaq
- Market Cap
- CDXC 415.5M
- ASPI 344.1M
- IPO Year
- CDXC N/A
- ASPI 2022
- Fundamental
- Price
- CDXC $5.48
- ASPI $4.94
- Analyst Decision
- CDXC Strong Buy
- ASPI Strong Buy
- Analyst Count
- CDXC 2
- ASPI 2
- Target Price
- CDXC $8.00
- ASPI $4.50
- AVG Volume (30 Days)
- CDXC 587.4K
- ASPI 2.8M
- Earning Date
- CDXC 10-31-2024
- ASPI 11-19-2024
- Dividend Yield
- CDXC N/A
- ASPI N/A
- EPS Growth
- CDXC N/A
- ASPI N/A
- EPS
- CDXC 0.02
- ASPI N/A
- Revenue
- CDXC $91,668,000.00
- ASPI $3,383,374.00
- Revenue This Year
- CDXC $18.64
- ASPI $1,760.86
- Revenue Next Year
- CDXC $20.72
- ASPI $315.19
- P/E Ratio
- CDXC $274.95
- ASPI N/A
- Revenue Growth
- CDXC 9.95
- ASPI N/A
- 52 Week Low
- CDXC $1.36
- ASPI $1.65
- 52 Week High
- CDXC $7.97
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- CDXC 39.30
- ASPI 48.42
- Support Level
- CDXC $5.26
- ASPI $4.21
- Resistance Level
- CDXC $5.56
- ASPI $5.21
- Average True Range (ATR)
- CDXC 0.29
- ASPI 0.59
- MACD
- CDXC -0.09
- ASPI 0.05
- Stochastic Oscillator
- CDXC 18.88
- ASPI 43.98
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.